Follow

Diamyd Medical AB

Nasdaq First North GM Stockholm (Sweden)

Diamyd Medical is a Sweden based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
DMYD B
SE0005162880
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Diamyd Medical AB with ticker DMYD B
Status
Active
Amount of instruments
69 013 573
Currency
SEK
Listing
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
DMYD B
SE0005162880
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Diamyd Medical AB with ticker DMYD B
Status
Active
Amount of instruments
69 013 573
Currency
SEK
Listing
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
DMYD TO 1 B
SE0009889199
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Diamyd Medical AB with ticker DMYD TO 1 B
Status
Archived
Amount of instruments
25 989 268
Currency
SEK
Trading period
29 Jun 2017 - 28 Nov 2018
Terms
Two (2) warrants entitles the holder to subscribe for a one (1) new share in the Company for SEK 4.55 per share during the subscription period from November 1, 2018 until November 30, 2018.
Update (19.06.2017): Trading in newly issued shares and warrants in Diamyd Medical starts on June 29, 2017.
Update (01.11.2018): The exercise period of warrants in Diamyd Medical begins today.
Update (26.11.2018): Diamyd Medical reminds of the exercise of warrants.
Exercise
Sign in to buy
People
Ulf Henrik Hannelius
CEO
Erik Nerpin
Chairman of the board
Anders Essen-Möller
Board member
Maria-Teresa Essen-Möller
Board member
Torbjörn Bäckström
Board member
Mark Atkinson
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Kungsgatan 29
Zip code
111 56
City/district
Stockholm
Country
Sweden (SE)
Registration number
556242-3797
LEI code
5493003NP2HNQDEKB804
First trade date
20 May 2013
Company former names
Diamyd Therapeutics AB
22 Apr 2013
BioSyn Holding AB
15 Jan 1999
Registration date
27 Mar 1984
Short name
Diamyd Medical

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More